SCHEMBL16237694

SCHEMBL16237694

COC(=O)c1c(C)nc(-c2nccs2)nc1-c1ccc(F)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.40
▸ VCP P55072 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ECE1 P42892 1/20 0.35
▸ ADORA1 P30542 2/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ BDKRB1 P46663 1/20 0.35
▸ DHFR P00374 1/20 0.35
▸ ABCG2 Q9UNQ0 1/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ BCR P11274 1/20 0.34
▸ GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17479068 0.91 ABL1 (0.39) KDM4EMAPTECE1ADORA1ADORA2A
SCHEMBL8166287 0.80 KDM4E (0.43) KDM4EMAPTMEN1ALDH1A1LMNA
SCHEMBL17479069 0.79 HCRTR1 (0.39) KDM4EECE1ADORA1ADORA2AALDH1A1
SCHEMBL15515454 0.79 CDC7 (0.43) KDM4EMAPTECE1ADORA1ALDH1A1
SCHEMBL17874029 0.78 SCN9A (0.37) ADORA1ADORA2ANPC1RAB9AABL1
SCHEMBL16237804 0.75 KMO (0.38) VCPECE1ADORA2AMEN1KMT2A
SCHEMBL16237658 0.74 LTA4H (0.36) ADORA1ADORA2A
SCHEMBL19259537 0.68 HCRTR1 (0.41) MAPTECE1ADORA1ADORA2AKMT2A
SCHEMBL19396111 0.68 PDPK1 (0.52) KDM4EVCPALDH1A1NPC1RAB9A
SCHEMBL3352615 0.67 KDM4E (0.53) KDM4EMAPTMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997032-A1 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2016-03-23 — — EP disclosed
WO-2014184328-A1 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-11-20 — — WO disclosed
Send feedback